[1] Kai H,Shinozaki Y,Nishikubo A,et al. Two autosomal dominant polycystic kidney (ADPKD) cases with advanced renal dysfunction,effectively treated with tolvaptan[J].CEN Case Rep,2016,5(1):87-90. [2] Song X,Haghighi A,Iliuta IA,et al.Molecular diagnosis of autosomal dominant polycystic kidney disease[J].Expert Rev Mol Diagn,2017,17(10):885-895. [3] 连小英,白雪源,张英杰.多囊肾细胞增殖和凋亡机制及治疗研究进展[J].解放军医学杂志,2016,41:949-954. [4] Kim DY,Park JH.Genetic mechanisms of ADPKD[J].Adv Exp Med Biol,2016,933:13-22. [5] Xu Y,Li A,Wu G,et al.Perspectives of gene therapies in autosomal dominant polycystic kidney disease[J].Curr Gene Ther,2017,17(1):43-49. [6] Potts JW,Mousa SA.Recent advances in management of Autosomal-dominant polycystic kidney disease[J].Am J Health Syst Pharm,2017,74(23):1959-1968. [7] Lemos FO,Ehrlich BE.Polycystin and calcium signaling in cell death and survival[J].Cell Calcium,2018,69:37-45. [8] Mangolini A,de Stephanis L,Aguiari G.Role of calcium in polycystic kidney disease:From signaling to pathology[J].World J Nephrol,2016,5(1):76-83. [9] Peintner L,Borner C.Role of apoptosis in the development of autosomal dominant polycystic kidney disease (ADPKD)[J].Cell Tissue Res,2017,369(1):27-39. [10] Fedeles SV,Gallagher AR,Somlo S.Polycystin-1:a master regulator of intersecting cystic pathways[J].Trends Mol Med,2014,20(5):251-260. [11] Merrick D,Bertuccio CA,Chapin HC,et al.Polycystin-1 cleavage and the regulation of transcriptional pathways[J].Pediatr Nephrol,2014,29(4):505-511. [12] Boletta A,Simons M,Walz L,et al.Polycystin-1,the gene product of PKD1,induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells[J].Mol Cell,2000,6(5):1267-1273. [13] Boca M,Boletta P,Simons M,et al.Polycystin-1 induces resistanceto apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway[J].J Am Soc Nephrol,2006,17(3):637-647. [14] Yu W,Kong T,Beaudry S,et al.Polycystin-1 protein level determines activity of the Galpha12/JNK apoptosis pathway[J].J Biol Chem,2010,285(14):10243-10251. [15] Tang Y,Wang Z,Yang J,et al.Polycystin-1 inhibits eIF2α phosphorylation and cell apoptosis through a PKR-eIF2α pathway[J].Sci Rep,2017,7(1):11493. [16] Gargalionis AN,Korkolopoulou P,Farmaki E,et al.Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer[J].Int J Cancer,2015,136(7):1515-1527. [17] Ibraghimov-Beskrovnaya O,Natoli TA.mTOR signaling in polycystic kidney disease[J].Trends Mol Med,2011,17(11):625-633. [18] Zhou J.Polycystins and primary cilia:primers for cell cycle progression[J].Annu Rev Physiol,2009,71:83-113. [19] Harris PC,Watson ML.Autosomal dominant polycystic kidney disease:neoplasia in disguise?[J].Nephrol Dial Transplant,1997,12(6):1089-1090. [20] Zheng R,Zhang Z,Lv X,et al.Polycystin-1 induced apoptosis and cell cycle arrest in G0/G1 phase in cancer cells[J].Cell Biol Int,2008,32(4):427-435. |